These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
627 related articles for article (PubMed ID: 15823769)
1. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women. Griffith SG; Dai Y Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769 [TBL] [Abstract][Full Text] [Related]
2. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive. Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781 [TBL] [Abstract][Full Text] [Related]
3. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy. Rosenfeld WE; Doose DR; Walker SA; Nayak RK Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594 [TBL] [Abstract][Full Text] [Related]
4. Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone. Trapnell CB; Donahue SR; Collins JM; Flockhart DA; Thacker D; Abernethy DR Clin Pharmacol Ther; 1998 Dec; 64(6):597-602. PubMed ID: 9871424 [TBL] [Abstract][Full Text] [Related]
5. Effect of vicriviroc with or without ritonavir on oral contraceptive pharmacokinetics: a randomized, open-label, parallel-group, fixed-sequence crossover trial in healthy women. Kasserra C; Li J; March B; O'Mara E Clin Ther; 2011 Oct; 33(10):1503-14. PubMed ID: 22015327 [TBL] [Abstract][Full Text] [Related]
6. Thalidomide does not alter estrogen-progesterone hormone single dose pharmacokinetics. Scheffler MR; Colburn W; Kook KA; Thomas SD Clin Pharmacol Ther; 1999 May; 65(5):483-90. PubMed ID: 10340913 [TBL] [Abstract][Full Text] [Related]
7. The interaction between St John's wort and an oral contraceptive. Hall SD; Wang Z; Huang SM; Hamman MA; Vasavada N; Adigun AQ; Hilligoss JK; Miller M; Gorski JC Clin Pharmacol Ther; 2003 Dec; 74(6):525-35. PubMed ID: 14663455 [TBL] [Abstract][Full Text] [Related]
8. Tazarotene does not affect the pharmacokinetics and efficacy of a norethindrone/ethinylestradiol oral contraceptive. Yu Z; Yu D; Walker PS; Tang-Liu DD Clin Pharmacokinet; 2004; 43(10):673-84. PubMed ID: 15244497 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic and pharmacodynamic interactions between the hepatitis C virus protease inhibitor, boceprevir, and the oral contraceptive ethinyl estradiol/norethindrone. Lin WH; Feng HP; Shadle CR; O'Reilly T; Wagner JA; Butterton JR Eur J Clin Pharmacol; 2014 Sep; 70(9):1107-13. PubMed ID: 24992979 [TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic and pharmacokinetic evaluation of coadministration of lacosamide and an oral contraceptive (levonorgestrel plus ethinylestradiol) in healthy female volunteers. Cawello W; Rosenkranz B; Schmid B; Wierich W Epilepsia; 2013 Mar; 54(3):530-6. PubMed ID: 23360419 [TBL] [Abstract][Full Text] [Related]
11. Effect of multiple-dose dexloxiglumide on the pharmacokinetics of oral contraceptives in healthy women. Roy P; Jakate AS; Patel A; Abramowitz W; Wangsa J; Persiani S; Kapil R J Clin Pharmacol; 2005 Mar; 45(3):329-36. PubMed ID: 15703367 [TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetics of sumatriptan when administered with norethindrone 1 mg/ethinyl estradiol 0.035 mg in healthy volunteers. Moore KH; McNeal S; Britto MR; Bye C; Sale M; Richardson MS Clin Ther; 2002 Nov; 24(11):1887-901. PubMed ID: 12501881 [TBL] [Abstract][Full Text] [Related]
13. A pharmacokinetic study with a low-dose oral contraceptive containing 20 microg ethinylestradiol plus 100 microg levonorgestrel. Endrikat J; Blode H; Gerlinger C; Rosenbaum P; Kuhnz W Eur J Contracept Reprod Health Care; 2002 Jun; 7(2):79-90. PubMed ID: 12201326 [TBL] [Abstract][Full Text] [Related]
14. Lack of effect of tenofovir disoproxil fumarate on pharmacokinetics of hormonal contraceptives. Kearney BP; Mathias A Pharmacotherapy; 2009 Aug; 29(8):924-9. PubMed ID: 19637945 [TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects. Sidhu J; Job S; Singh S; Philipson R Br J Clin Pharmacol; 2006 Feb; 61(2):191-9. PubMed ID: 16433873 [TBL] [Abstract][Full Text] [Related]
17. Effect of laropiprant, a PGD2 receptor 1 antagonist, on estradiol and norgestimate pharmacokinetics after oral contraceptive administration in women. Schwartz JI; Liu F; Wang YH; Pramanik B; Johnson-Levonas AO; Gutierrez MJ; Lai E; Wagner JA Am J Ther; 2009; 16(6):487-95. PubMed ID: 19940609 [TBL] [Abstract][Full Text] [Related]
18. Assessment of disease-drug-drug interaction between single-dose tocilizumab and oral contraceptives in women with active rheumatoid arthritis. Zhang X; Rowell L; Fettner S; Lau C; Teuber D Int J Clin Pharmacol Ther; 2014 Jan; 52(1):27-38. PubMed ID: 24161161 [TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetic interaction between an oral contraceptive containing ethinyl estradiol and norethindrone and the HCV protease inhibitor telaprevir. Garg V; van Heeswijk R; Yang Y; Kauffman R; Smith F; Adda N J Clin Pharmacol; 2012 Oct; 52(10):1574-83. PubMed ID: 22039291 [TBL] [Abstract][Full Text] [Related]
20. Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects. Doose DR; Wang SS; Padmanabhan M; Schwabe S; Jacobs D; Bialer M Epilepsia; 2003 Apr; 44(4):540-9. PubMed ID: 12681003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]